ZVRA Wichtige Statistiken
Hoch
9.99
Öffnen
9.53
Volumen
1.51M
Niedrig
9.47
Vorheriger Schlusskurs
9.53
Handelswert
14.76M
52W-Hoch
15.04
Rel. Volumen
0.961
Amplitude (%)
5.46%
52W-Tief
7.16
Umsatzrate
2.57%
Marktkapitalisierung
563.07M
KGV (TTM)
4.42
KGV (Jährlich)
6.807
KBV
2.74
KUV
4.61
Gewinn je Aktie (EPS)
2.154
Dividende (TTM)
0
Dividendenrendite
0.00%
Ausstehende Aktien
59.11M
Währung
USD
ZVRA Preis-Performance
7 Tag
30 Tag
90 Tag
180 Tag
Seit Jahresbeginn
1 Jahr
ZVRA Moneyflow-Verteilung
ZVRA Tägliches Leerverkaufsvolumen
ZVRA Short-Interest-Historie
ZVRA Aktien-Snapshot
As of 2026-07-27, the Zevra Therapeutics, Inc. (ZVRA) stock price today is 9.71. Based on this price, the company has a market capitalization of $563.07M, with a P/E ratio of 4.42.
On 2026-07-27, ZVRA traded between 9.47 and 9.99. Today’s stock price is 2.53% above the daily low and 2.80% below the daily high, placing ZVRA in der Mitte von its most recent trading range.
Trading volume currently stands at 1.51M, compared with an average daily volume of 1.58M. This suggests that trading activity is ungefähr im Einklang mit dem üblichen Niveau than usual.
Over the past year, Zevra Therapeutics, Inc. shares have traded between 7.16 and 15.04. At today’s price, ZVRA is 35.61% above its 52-week low and 35.44% below its 52-week high.
ZVRA Verwandte Nachrichten
Über ZVRA
Firmenname
Zevra Therapeutics, Inc.
Sektor
Health Technology
Branche
Pharmaceuticals: Major
Börsen
Nasdaq
Anzahl der Beschäftigten
61
Losgröße
100
Offizielle Website
Währung
USD
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Related Stocks
ZVRA FAQ
© 2026 CoinGlass, all rights reserved
